Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension


Kim N. H., D'Armini A. M., Grimminger F., Gruenig E., Hoeper M. M., Jansa P., ...More

HEART, vol.103, no.8, pp.599-606, 2017 (SCI-Expanded, Scopus) identifier

  • Publication Type: Article / Article
  • Volume: 103 Issue: 8
  • Publication Date: 2017
  • Doi Number: 10.1136/heartjnl-2016-309621
  • Journal Name: HEART
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.599-606
  • Istanbul University Affiliated: No

Abstract

Objective We compared the haemodynamic effects of riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or persistent/recurrent CTEPH after pulmonary endarterectomy in the Chronic Thromboembolic Pulmonary Hypertension Soluble Guanylate CyclaseStimulator Trial 1 study.